bims-malgliBiology of malignant gliomas
This report is maintained by Oltea Sampetrean, Keio University. It brings out roughly 10 papers per issue.
0000‒00‒00
 Sign up
2025–12–07
2025–11–30
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2025–11–23
2025–11–16
2025–11–09
2025–11–02
2025–10–26
2025–10–19
2025–10–12
2025–10–05
2025–09–28
2025–09–21
2025–09–14
2025–09–07
2025–08–31
2025–08–24
2025–08–17
2025–08–10
2025–08–03
2025–07–27
2025–07–20
2025–07–13
2025–07–06
2025–06–29
2025–06–22
2025–06–15
2025–06–08
2025–06–01
2025–05–25
2025–05–18
2025–05–11
2025–05–04
2025–04–27
2025–04–20
2025–04–13
2025–04–06
2025–03–30
2025–03–23
2025–03–16
2025–03–09
2025–03–02
2025–02–23
2025–02–16
2025–02–09
2025–02–02
2025–01–26
2025–01–19
2025–01–12
2025–01–05
2024–12–29
2024–12–22
2024–12–15
2024–12–08
2024–12–01
2024–11–24
2024–11–17
2024–11–10
2024–11–03
2024–10–27
2024–10–20
2024–10–13
2024–10–06
2024–09–29
2024–09–22
2024–09–15
2024–09–08
2024–09–01
2024–08–25
2024–08–18
2024–08–11
2024–08–04
2024–07–28
2024–07–21
2024–07–14
2024–07–07
2024–06–30
2024–06–23
2024–06–16
2024–06–09
2024–06–02
2024–05–26
2024–05–19
2024–05–12
2024–05–05
2024–04–28
2024–04–21
2024–04–14
2024–04–07
2024–03–31
2024–03–24
2024–03–17
2024–03–10
2024–03–03
2024–02–25
2024–02–18
2024–02–11
2024–02–04
2024–01–28
2024–01–21
2024–01–14
2024–01–07
2023–12–31
2023–12–24
2023–12–17
2023–12–10
2023–12–03
2023–11–26
2023–11–19
2023–11–12
2023–11–05
2023–10–29
2023–10–22
2023–10–15
2023–10–08
2023–10–01
2023–09–24
2023–09–17
2023–09–10
2023–09–03
2023–08–27
2023–08–20
2023–08–13
2023–08–06
2023–07–30
2023–07–23
2023–07–16
2023–07–09
2023–07–02
2023–06–25
2023–06–18
2023–06–11
2023–06–04
2023–05–28
2023–05–21
2023–05–14
2023–05–07
2023–04–30
2023–04–23
2023–04–16
2023–04–09
2023–04–02
2023–03–26
2023–03–19
2023–03–12
2023–03–05
2023–02–26
2023–02–19
2023–02–12
2023–02–05
2023–01–29
2023–01–22
2023–01–15
2023–01–08
2023–01–01
2022–12–25
2022–12–18
2022–12–11
2022–12–04
2022–11–27
2022–11–20
2022–11–13
2022–11–06
2022–10–30
2022–10–23
2022–10–16
2022–10–09
2022–10–02
2022–09–25
2022–09–18
2022–09–11
2022–09–04
2022–08–28
2022–08–21
2022–08–14
2022–08–07
2022–07–31
2022–07–24
2022–07–17
2022–07–10
2022–07–03
2022–06–26
2022–06–19
2022–06–12
2022–06–05
2022–05–29
2022–05–22
2022–05–15
2022–05–08
2022–05–01
2022–04–24
2022–04–17
2022–04–10
2022–04–03
2022–03–27
2022–03–20
2022–03–13
2022–03–06
2022–02–27
2022–02–20
2022–02–13
2022–02–06
2022–01–30
2022–01–23
2022–01–16
2022–01–09
2022–01–02
2021–12–26
2021–12–19
2021–12–12
2021–12–05
2021–11–28
2021–11–21
2021–11–14
2021–11–07
2021–10–31
2021–10–24
2021–10–17
2021–10–10
2021–10–03
2021–09–26
2021–09–19
2021–09–12
2021–09–05
2021–08–29
2021–08–22
2021–08–15
2021–08–08
2021–08–01
2021–07–25
2021–07–18
2021–07–11
2021–07–04
2021–06–27
2021–06–20
2021–06–13
2021–06–06
2021–05–30
2021–05–23
2021–05–16
2021–05–09
2021–05–02
2021–04–25
2021–04–18
2021–04–11
2021–04–04
2021–03–28
2021–03–21
2021–03–14
2021–03–07
2021–02–28
2021–02–21
2021–02–14
2021–02–07
2021–01–31
2021–01–24
2021–01–17
2021–01–10
2021–01–03
2020–12–27
2020–12–20
2020–12–13
2020–12–06
2020–11–29
2020–11–22
2020–11–15
2020–11–08
2020–11–01
2020–10–25
2020–10–18
2020–10–11
2020–10–04
2020–09–27
2020–09–20
2020–09–13
2020–09–06
2020–08–30
2020–08–23
2020–08–16
2020–08–09
2020–08–02
2020–07–26
2020–07–19
2020–07–12
2020–07–05
2020–06–28
2020–06–21
2020–06–14
Oltea Sampetrean also maintains a report bims-mecami on “Metabolic interactions between cancer cells and their microenvironment” since 2023–03–12.
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meract“Metabolic reprogramming and anti-cancer therapy”, ∼ 15 p.p.i. ∼ 15 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-medica“Metabolism and diet in cancer”, ∼ 24 p.p.i. ∼ 24 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-unfpre“Unfolded protein response”, ∼ 8 p.p.i. ∼ 8 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-caglex“Cellular aging and life extension”, ∼ 23 p.p.i. ∼ 23 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-carter“CAR-T Therapies”, ∼ 30 p.p.i. ∼ 30 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-tumhet“Tumor heterogeneity”, ∼ 8 p.p.i. ∼ 8 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-myxlip“Myxoid liposarcoma”, ∼ 1 p.p.i. ∼ 1 paper per issue
This page is being maintained by Thomas Krichel. It was last updated on 2025‒12‒07 at 0:10.